Several studies of breast cancer and melanoma have shown that gene amplification contributes to PHGDH overexpression [24, 38] and that PHGDH expression can be upregulated by the transcription factor NRF2 in non-small cell lung cancer [29]. This evidence concerns the gene PHGDH and non-small cell lung carcinoma.